HOME >> MEDICINE >> NEWS
Common osteoporosis treatment may help men with prostate cancer suffering from bone loss

inistered.

"Since most men with prostate cancer remain on androgen deprivation therapy for an indefinite amount of time, bone loss can be a serious and long-term side effect from therapy," said Joel Nelson, M.D., co-author of the study and professor and chairman of the department of urology at the University of Pittsburgh School of Medicine. "With more than 230,000 men being diagnosed with prostate cancer each year, the addition of alendronate therapy could help to prevent the incidence of debilitating bone fractures."

Androgen deprivation therapy works by depriving the body of testosterone, an androgen hormone that increases the growth of prostate tumors. However, testosterone also is essential to maintaining bone mass in men. While doctors have been using this type of therapy for more than a decade to treat men with late-stage metastatic prostate cancer, they have begun using it more recently in men with earlier-stage disease and for longer periods of time; this increased exposure increases the risk for developing osteoporosis.

"These results suggest to us that men who are under treatment for prostate cancer should be encouraged to get a bone density test and that those at risk could benefit greatly from bone-preserving therapy," said Dr. Greenspan.


'"/>


25-Feb-2006


Page: 1 2

Related medicine news :

1. Commonly used drug offers promise for premature babies
2. Commonly used pain medications do not prevent Alzheimers disease
3. Common anesthetic may induce cell death, generation of Alzheimers-associated protein
4. Common blood pressure drug treats muscular dystrophy in mice
5. Common PTSD drug is no more effective than placebo
6. Common cold may be just a fingertip away due to environmental contamination
7. Commonwealth Fund commission says the US health care system needs thorough transformation
8. Commonly recommended sedative does not improve infant sleep
9. Common asthma inhaler causing deaths, researchers assert
10. Common painkillers associated with increased risk of first hospital admission for heart failure
11. Commonly used blood pressure medication prevents aortic aneurysm in mice with Marfan syndrome

Post Your Comments:
(Date:8/31/2015)... ... , ... On Saturday, July 11, 2015, during the annual New York State ... was proud to recognize Dr. Merritt F. Spear as the 2015 recipient of the ... long-time NYSATA member and Ithaca College athletic trainer and educator, is considered for individuals ...
(Date:8/31/2015)... ... ... Adult & Pediatric Dermatology in Greenwood Village, CO has launched a new ... services available to help them. , The website better showcases the practice to ... to view the website seamlessly on any desktop computer, tablet or mobile device. , ...
(Date:8/31/2015)... ... ... The Marietta dentists and staff at Verde Pointe Dental Associates ... staff ran a 5K race, the Iron Horse for Enduring Hearts on August 30th, ... the event to help support projects with funding to increase understanding of clinical and ...
(Date:8/30/2015)... ... 31, 2015 , ... Negotiating an FDA Import Hold Crisis:, Strategies for Challenging ... http://www.fdanews.com/importholdcrisis , US authorities are holding imports more than ever before, particularly ... With alerts on an uptick and a new final rule, having a top-notch import ...
(Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... ... across platforms and devices, today announced it is a Silver Sponsor of the ... at Sky City Convention Centre in Auckland, NZ. Throughout the event, AvePoint will ...
Breaking Medicine News(10 mins):Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 3Health News:Adult & Pediatric Dermatology Launches Responsive Design Website 2Health News:Adult & Pediatric Dermatology Launches Responsive Design Website 3Health News:Verde Pointe Dental Associates Runs a 5K for Enduring Hearts 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 2Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 4
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Developed by Roche under the trade name ... in the world. In Feb.26, 2010, it was approved ... injections available in China all ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... report to their offering. Developed by ... Seroquel) is an important drug for the treatment ... in 2000, quetiapine was listed in the Catalogue ...
(Date:8/28/2015)... N.J. , Aug. 28, 2015  IP Shakti, LLC, ... LLC. ... "Our new corporate identity signifies our transformation ... world,s first predictive analytics platform for patent claim validity." ... the launch of the proprietary AIA Shield™ platform, the Company ...
Breaking Medicine Technology:Investigation Report on China's Bevacizumab Market 2015-2019 2China Quetiapine Market Investigation Report 2010-2019 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
Cached News: